AtriCure, Inc.
ATRC
$29.78
$0.250.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 111.28% | 96.60% | 22.70% | 49.15% | -59.04% |
| Total Depreciation and Amortization | 5.82% | 4.89% | 14.23% | 14.20% | 15.48% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 88.89% | -31.82% | -2.46% |
| Total Other Non-Cash Items | -45.84% | 21.64% | 50.79% | -7.31% | 138.02% |
| Change in Net Operating Assets | 101.86% | -27.74% | 9,947.62% | 15.84% | -1,387.10% |
| Cash from Operations | 243.16% | 33.55% | 192.91% | 47.54% | 44.81% |
| Capital Expenditure | 40.51% | 27.80% | -11.66% | 21.38% | 3.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.67% | -100.00% | -115.04% | -95.97% | -- |
| Cash from Investing | 82.29% | -159.31% | -124.80% | -117.43% | -427.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.23% | -11.90% | -10.61% | 99.54% | -7.66% |
| Issuance of Common Stock | 19.72% | 493.94% | 20.42% | -65.64% | -18.23% |
| Repurchase of Common Stock | -18.75% | -466.67% | -155.35% | -55.61% | -128.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.71% | 1,897.00% | 19.80% | -31.33% | -26.32% |
| Foreign Exchange rate Adjustments | 108.08% | -110.97% | 1,042.11% | 279.82% | -554.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 356.93% | 23.74% | -56.39% | -18.06% | -305.12% |